Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$315,375
+$65,239 QoQ
Shares Held
13,097
+47.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,091
of 2,820 holders
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Asset Management, LLC holds $14,808,473 across 9 Drug Manufacturers - General names. PFE ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,661 | $5,590,543 | |
| 2 | JNJ |
Johnson & Johnson
|
8,572 | $2,177,030 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,535 | $1,996,247 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
13,735 | $1,735,279 | |
| 5 | ABBV |
AbbVie Inc.
|
5,575 | $1,402,893 | |
| 6 | AMGN |
Amgen Inc
|
2,925 | $1,059,201 | |
| 7 | PFE |
Pfizer Inc
This page
|
13,097 | $315,375 | |
| 8 | GSK |
GSK plc
|
5,455 | $285,951 |
All Filings in PFE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $315,375 | 13,097 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $250,136 | 8,908 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $267,251 | 10,733 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $313,658 | 12,310 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $262,713 | 10,838 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $267,894 | 10,572 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,316,471 | 49,622 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $297,098 | 10,266 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $327,002 | 11,687 | Shares | Sole | 2024-08-12 | |
| 2022-12-31 | $356,118 | 6,950 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $210,835 | 4,818 | Shares | Sole | 2022-10-19 | |
| No filing history on record for this holder in this stock. | ||||||